Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy
- 17 June 2008
- journal article
- case report
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 5 (8) , 487-491
- https://doi.org/10.1038/ncponc1157
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Genetic Causes of Brain Tumors: Neurofibromatosis, Tuberous Sclerosis, von Hippel-Lindau, and Other SyndromesNeurologic Clinics, 2007
- Contact-dependent inhibition of EGFR signaling by Nf2/MerlinThe Journal of cell biology, 2007
- STEREOTACTIC RADIOSURGERY FOR VESTIBULAR SCHWANNOMAS IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2Neurosurgery, 2007
- Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromesJournal of Medical Genetics, 2005
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Management of the patient and family with neurofibromatosis 2: a consensus conference statementBritish Journal Of Neurosurgery, 2005
- Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosisJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Multichannel auditory brainstem implant: update on performance in 61 patientsJournal of Neurosurgery, 2002
- Voice Fundamental Frequency as an Auditory Supplement to the Speechreading of SentencesEar & Hearing, 1988
- Interim Assessment of Candidates for Cochlear ImplantsJAMA Otolaryngology–Head & Neck Surgery, 1982